novartis ag-sponsored adr
(NVS:New York Consolidated)
Chief Financial Officer, Novartis AG
|Age||Total Calculated Compensation||This person is connected to 13 board members in 1 different organizations across 1 different industries.|
See Board Relationships
As of Fiscal Year 2014
Mr. Harry Kirsch has been the Chief Financial Officer of Novartis AG since May 1, 2013. Mr. Kirsch joined Novartis in 2003 and served as Chief Financial Officer of Pharmaceuticals until May 01, 2013. He served at Procter & Gamble. He serves as a Director of advisory board of Novartis Venture Funds. Mr. Kirsch studied industrial engineering and economics at the university of karlsruhe in Germany ("Diplom Wirtschaftsingenieur").
Lichtstrasse 35Phone: 41 61 324 11 11
Basel, Basel-Stadt 4056
Board Members Memberships*There is no Board Members Memberships data available.
Karlsruhe Institute of Technology
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Alex Gorsky||Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee|
Johnson & Johnson
|Ian C. Read||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Kenneth C. Frazier||Chairman, Chief Executive Officer and President|
Merck & Co. Inc.
|Severin Schwan Ph.D.||Chief Executive Officer and Director|
Roche Holding AG
|SFr.5.3M||Compensation as of Fiscal Year 2013.|